In triple-negative breast cancer, miR-374a is upregulated relative to levels in non-tumor tissues and promotes cell proliferation, migration, and tumor progression in vivo by targeting arrestin-β1 (ARRB1) [36]. Here, ARRB1 is linked to neoplasm.